| scholarly article | Q13442814 |
| P50 | author | George M Carlone | Q106918891 |
| Jacquelyn S Sampson | Q106930492 | ||
| Helena Käyhty | Q111990066 | ||
| P2093 | author name string | Paton JC | |
| Briles DE | |||
| Takala AK | |||
| Jäntti V | |||
| Haikala R | |||
| Rapola S | |||
| Kilpi TM | |||
| Syrjänen R | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| acute otitis media | Q864028 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1146-1152 | |
| P577 | publication date | 2000-09-05 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media | |
| P478 | volume | 182 |
| Q40176136 | A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi |
| Q37606439 | A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media |
| Q35959243 | ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies |
| Q35586932 | Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue. |
| Q36527882 | Adenoidectomy and tympanostomy tubes in the management of otitis media |
| Q35999563 | Advances in pneumococcal vaccines: advantages for infants and children |
| Q35690666 | Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci |
| Q77723452 | Age-dependent preference in human antibody responses to Streptococcus pneumoniae polypeptide antigens |
| Q34145758 | Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya |
| Q73816606 | Anti-PsaA and the risk of pneumococcal AOM and carriage |
| Q34033275 | Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model |
| Q37213916 | Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage |
| Q37668036 | Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development |
| Q41589432 | Antibody in middle ear fluid of children originates predominantly from sera and nasopharyngeal secretions |
| Q24809188 | Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? |
| Q39051818 | Association of Pneumococcal Protein Antigen Serology With Age and Antigenic Profile of Colonizing Isolates |
| Q38395713 | Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children |
| Q38984614 | Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens |
| Q79836550 | Bacterial coinfections in children with viral wheezing |
| Q37264678 | CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice |
| Q33935327 | CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization |
| Q38124921 | Current status and perspectives on protein-based pneumococcal vaccines |
| Q28386732 | Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins |
| Q40497431 | Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media |
| Q36933011 | Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae |
| Q81098313 | Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage |
| Q33798317 | Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage |
| Q36384449 | Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae. |
| Q37470654 | Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults |
| Q36898018 | Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins |
| Q34854559 | Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice |
| Q34547849 | Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance |
| Q34794776 | Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children |
| Q40285793 | Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection |
| Q34477702 | IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media. |
| Q39656521 | Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children |
| Q33963100 | Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine |
| Q36191655 | Impaired function of antibodies to pneumococcal surface protein A but not to capsular polysaccharide in Mexican American adults with type 2 diabetes mellitus |
| Q33800556 | Incomplete recovery of pneumococcal CD4 T cell immunity after initiation of antiretroviral therapy in HIV-infected malawian adults |
| Q43196580 | Induction of in vivo antipolysaccharide immunoglobulin responses to intact Streptococcus pneumoniae is more heavily dependent on Btk-mediated B-cell receptor signaling than antiprotein responses |
| Q44240299 | Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children |
| Q34779050 | Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies |
| Q33370537 | Interleukin-17A mediates acquired immunity to pneumococcal colonization |
| Q58596157 | Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation |
| Q34975824 | Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice |
| Q37410062 | Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants |
| Q28743311 | Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring |
| Q35155588 | Modern management of acute otitis media |
| Q37252358 | Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A |
| Q35588006 | Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria |
| Q36087567 | Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection |
| Q36689018 | Nasopharyngeal colonization: a target for pneumococcal vaccination |
| Q37396978 | Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life |
| Q47981601 | Natural materno-fetal transfer of antibodies to PspA and to PsaA. |
| Q37282316 | Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines |
| Q35192429 | Novel vaccine strategies with protein antigens of Streptococcus pneumoniae |
| Q37683735 | Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides. |
| Q84067441 | Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children |
| Q38923654 | Pneumococcal lipoproteins involved in bacterial fitness, virulence, and immune evasion. |
| Q37035066 | Pneumococcal serology in children's respiratory infections |
| Q37279975 | Pneumococcal surface adhesin A (PsaA): a review |
| Q44002546 | Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults. |
| Q35776558 | Pneumococcal vaccines: an update on current strategies. |
| Q97883476 | Pneumolysin: Pathogenesis and Therapeutic Target |
| Q33202131 | Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins |
| Q33973333 | Quantitative detection of Streptococcus pneumoniae in nasopharyngeal secretions by real-time PCR |
| Q37309218 | Rationale and prospects for novel pneumococcal vaccines |
| Q37309298 | Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study |
| Q40211674 | Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial. |
| Q42230169 | Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. |
| Q38059914 | Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults |
| Q40215132 | Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study |
| Q40046987 | Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants |
| Q100514970 | Seroepidemiological analysis of anti-pneumococcal surface protein A (PspA) immunoglobulin G by clades in Japanese population |
| Q38069943 | Serotype-independent pneumococcal vaccines. |
| Q36452316 | Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. |
| Q46846171 | Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status |
| Q35075156 | Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media |
| Q34803614 | Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study |
| Q39912979 | Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization |
| Q24684017 | Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children |
| Q35887453 | Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children |
| Q57456601 | Th17 responses to pneumococcus in blood and adenoidal cells in children |
| Q53083052 | Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. |
| Q34041104 | The oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae |
| Q43078345 | Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae. |
| Q81369539 | Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry |
Search more.